Clinical Trial Update: Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating celecoxib for prevention of lung cancer in tobacco smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED